Medicinal Plant Biotechnology 2010
DOI: 10.1079/9781845936785.0013
|View full text |Cite
|
Sign up to set email alerts
|

Medicinal compounds produced in plant cell factories.

Abstract: This chapter highlights the role of plants as an important source of new drugs and as a source of lead compounds for the design and development of novel pharmaceuticals for research and development. It describes current technologies used for the production of medicinal compounds in plant cell cultures. It also discusses future prospects in plant metabolic engineering and its role in the efficient production of plant secondary metabolites.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…In comparison to cell suspensions, HRCs present several advantages such as genotypic and phenotypic stability and possible extracellular secretion of expressed proteins (also referred to as rhizosecretion) offering a convenient method for target proteins purification in a well-defined protein-deficient medium (Wang and Wu, 2013). HRCs are capable for the production of complex compounds and high scalability (Häkkinen and Ritala, 2010;Stoger et al, 2014). In this context, the production of recombinant proteins has been considered a promising application of HRCs.…”
Section: Introductionmentioning
confidence: 99%
“…In comparison to cell suspensions, HRCs present several advantages such as genotypic and phenotypic stability and possible extracellular secretion of expressed proteins (also referred to as rhizosecretion) offering a convenient method for target proteins purification in a well-defined protein-deficient medium (Wang and Wu, 2013). HRCs are capable for the production of complex compounds and high scalability (Häkkinen and Ritala, 2010;Stoger et al, 2014). In this context, the production of recombinant proteins has been considered a promising application of HRCs.…”
Section: Introductionmentioning
confidence: 99%
“…Plant‐based production systems can be used to manufacture valuable pharmaceutical and industrial proteins, an approach known as molecular farming (Häkkinen and Ritala, ; Ma et al, ). The advantages of plants include the cost‐effective propagation of biomass, the ability to carry out complex post‐translational modifications similar to mammalian cells, and the absence of endotoxins and human pathogens (Twyman et al, ).…”
Section: Introductionmentioning
confidence: 99%
“…Future work will therefore focus on the establishment of further hairy root clones starting from high yielding Edelweiss genotypes, and using additional A. rhizogenes strains. In any case, as a continuous, sustainable and renewable production system independent of climatic or environmental effects [45] the biotechnological production of leoligin and 5-methoxy-leoligin would be of advantage over the extraction from field grown plants.…”
Section: Discussionmentioning
confidence: 99%